Intuitive Surgical filings document operating results, governance matters, capital structure, and material events for a Nasdaq-listed medical technology company focused on robotic-assisted surgery. Its Form 8-K reports furnish quarterly and preliminary financial results, procedure information, and exhibits tied to da Vinci and Ion business performance.
Regulatory filings also cover shareholder voting matters, proxy governance, executive compensation, director elections, and officer-role changes. Other material-event disclosures record completed corporate actions, including the acquisition of da Vinci and Ion distribution operations in Europe, alongside formal disclosures about common stock and financial reporting matters.
Intuitive Surgical, Inc. (ISRG) officer Fredrik Widman filed a notice of a proposed sale of 4,359 common shares, with a listed aggregate market value of $1,956,144.84. The notice lists the shares as acquired from the issuer through exercise of stock options for cash on October 30, 2026. It also identifies three earlier sales as 10b5-1 sales: 4,047 shares on October 23, 2026, and 546 and 543 shares on September 15, 2026.
Intuitive Surgical (ISRG) EVP Mark Brosius reported selling 61 shares of Common Stock on each of October 26, October 27 and October 28, 2026. The reported prices were $451.75, $451.63 and $441.60 per share, respectively. Each sale took place under a Trading Plan that complies with SEC Rule 10b5-1 and expires February 14, 2027.
Craig H. Barratt, an Intuitive Surgical director, exercised 1,150 non-qualified stock options at $90.4944 per share on October 23, 2026, acquiring 1,150 common shares, and sold 1,150 common shares at $443.80 per share that day. The transactions were under a Rule 10b5-1 trading plan expiring March 15, 2027. Afterward, 3,485 options remained; a separate holding entry lists 27,948 shares held indirectly by a trust.
Intuitive Surgical Inc. (ISRG) VP Corporate Controller Fredrik Widman exercised 11 non-qualified stock options on October 23, 2026, acquiring 4,047 common shares, and sold 4,047 common shares at a weighted-average price of $453.2059 per share. The sale executions ranged from $444.44 to $458.02 per share. The transactions were reported under a Rule 10b5-1 trading plan expiring September 15, 2027.
Intuitive Surgical Inc. officer Patricia L. Wadors sold 1,078 shares of common stock at $443.80 per share on October 23, 2026. Her reported direct common-stock holdings after the sale were 0 shares. The sale was made under a Rule 10b5-1 Trading Plan.
Intuitive Surgical (ISRG) director Gary S. Guthart reported the sale of 20,095 shares held indirectly by a Trust on October 23, 2026, at a weighted average sale price of $451.6117 per share. The reported post-sale position held through a Trust was 1,204,530 shares. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2027. The reported indirect holdings also included 26,247 shares in a Trust FBO Daughter and 26,247 shares in a Trust FBO Son.
Intuitive Surgical, Inc. (ISRG) officer Fredrik Widman filed a Rule 144 notice covering the proposed sale of 5,136 common shares, with an aggregate market value of $2,279,613.60 and an approximate sale date of October 23, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The shares are to be received through stock-option exercises over the next three months. The notice also lists two September 15, 2026 sales in a section labeled “10b5-1 Sales”: 546 shares for $204,444.24 and 543 shares for $203,320.92.
Intuitive Surgical, Inc. director Gary Guthart, signing as trustee, submitted a notice concerning the proposed sale of 27,139 common shares for the account of the Guthart Family Trust. The notice lists an aggregate market value of $12,045,645.15, an approximate sale date of October 23, 2026, and Morgan Stanley Smith Barney LLC in the broker field.
The shares are identified as acquired upon vesting of restricted stock units and performance stock units during the period from February 15, 2022, through February 28, 2025.
Intuitive Surgical, Inc. (ISRG) is the issuer in a notice naming Director Craig H. Barratt’s proposed sale of 1,150 common shares, with an aggregate market value of $510,427.50. Morgan Stanley Smith Barney LLC is listed as broker, October 23, 2026 as the approximate sale date, and NASDAQ as the exchange.
Intuitive Surgical, Inc. (ISRG) Officer Patricia Wadors gave notice of a proposed sale of 1,078 common shares, with an approximate sale date of October 23, 2026. The notice reports an aggregate market value of $478,470.30. The acquisition details list restricted stock units from the issuer dated October 10, 2026.